Nishimura Y, Fukuoka N, Fukuyoshi Y, Matsuo Y, Yamaguchi K, Takatsuki K
Blood Transfusion Service, Kumamoto University Hospital.
Rinsho Byori. 1990 Dec;38(12):1363-7.
EIA (Eitest: Eisai) and Gelatin Particle Agglutination: PA (SERODIA: Fujirebio) assays were performed for the detection of HTLV-I antibodies with 10,780 sera from patients since 1986. Eleven point five percent were reactive by both EIA and PA, while 1.1% was PA(+), EIA(-), these PA false positive occurred on low titer. Conversely 0.2% on EIA positive seems PA false negative because of Western blot (WB) positivity. Zero point nine percent was EIA(+), PA(-), of these 80.6% were not inhibited by EIA confirmatory test. The main cause of EIA false positive was due to reactivity of auto antibody with MT-2 cell lysate. We used new EIA (ED-007: Eisai) coated with HTLV-I antigen purified from supernatant of culture medium of MT-2 cell. The results completely matched with EIA confirmatory test and WB. Cut off index value of sera from SLE patients were down to 0.2 (mean +/- SD) from 0.7 +/- 0.4 of Eitest ATL. EIA (ED-007) are probably useful and more specific assays for the detection of HTLV-I antibodies, especially, the sera of patients with autoimmune diseases.
自1986年起,使用酶免疫分析(EIA,Eitest:卫材)和明胶颗粒凝集试验:PA(SERODIA:富士瑞必欧)对10780例患者血清进行检测以检测HTLV - I抗体。11.5%的样本在EIA和PA检测中均呈阳性反应,而1.1%的样本PA阳性、EIA阴性,这些PA假阳性出现在低滴度样本中。相反,由于免疫印迹(WB)呈阳性,EIA阳性样本中0.2%似乎为PA假阴性。0.9%的样本EIA阳性、PA阴性,其中80.6%未被EIA确证试验抑制。EIA假阳性的主要原因是自身抗体与MT - 2细胞裂解物发生反应。我们使用了用从MT - 2细胞培养基上清液中纯化的HTLV - I抗原包被的新型EIA(ED - 007:卫材)。结果与EIA确证试验和WB完全匹配。SLE患者血清的截断指数值从Eitest ATL的0.7±0.4降至0.2(平均值±标准差)。EIA(ED - 007)可能是检测HTLV - I抗体,特别是自身免疫性疾病患者血清的有用且更具特异性的检测方法。